Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Stoke Therapeutics
STOK
$2.02B
| $9.24M | ﹤0.01% |
363,335
+7,089
| +2% | +$198K |
|
|
REVG
2502
DELISTED
REV Group
REVG
| $9.24M | ﹤0.01% |
538,604
+79,201
| +17% | +$1.26M |
|
|
DHIL
2503
DELISTED
Diamond Hill
DHIL
| $9.23M | ﹤0.01% |
52,565
-89
| -0.2% | -$15.6K |
|
2504
OneSpaWorld
OSW
$2.73B
| $9.23M | ﹤0.01% |
925,937
+290
| +0% | +$2.86K |
|
2505
4D Molecular Therapeutics
FDMT
$621M
| $9.23M | ﹤0.01% |
342,218
+174,784
| +104% | +$4.98M |
|
2506
Metallus
MTUS
$900M
| $9.23M | ﹤0.01% |
705,570
+11,194
| +2% | +$153K |
|
|
RMO
2507
DELISTED
Romeo Power, Inc.
RMO
| $9.2M | ﹤0.01% |
1,858,426
+773,911
| +71% | +$4.63M |
|
2508
Ooma
OOMA
$553M
| $9.19M | ﹤0.01% |
494,054
+35,976
| +8% | +$677K |
|
|
SQSP
2509
DELISTED
Squarespace, Inc.
SQSP
| $9.19M | ﹤0.01% |
+237,918
| New | +$11.5M |
|
2510
DXP Enterprises
DXPE
$3.04B
| $9.17M | ﹤0.01% |
310,252
+9,648
| +3% | +$296K |
|
2511
Veru
VERU
$46M
| $9.12M | ﹤0.01% |
106,918
+2,218
| +2% | +$176K |
|
2512
Ethan Allen Interiors
ETD
$575M
| $9.12M | ﹤0.01% |
384,771
+12,478
| +3% | +$308K |
|
2513
i3 Verticals
IIIV
$323M
| $9.12M | ﹤0.01% |
376,639
+12,506
| +3% | +$361K |
|
|
CHS
2514
DELISTED
Chicos FAS, Inc.
CHS
| $9.12M | ﹤0.01% |
2,030,804
+24,621
| +1% | +$141K |
|
2515
Phathom Pharmaceuticals
PHAT
$743M
| $9.11M | ﹤0.01% |
283,863
+2,490
| +0.9% | +$82.7K |
|
2516
Playboy Inc
PLBY
$149M
| $9.11M | ﹤0.01% |
386,459
+117,998
| +44% | +$3.17M |
|
2517
Midland States Bancorp
MSBI
$698M
| $9.1M | ﹤0.01% |
367,832
-2,441
| -0.7% | -$60.8K |
|
2518
GeneDx Holdings
WGS
$2.46B
| $9.08M | ﹤0.01% |
36,269
+35,481
| +4,503% | +$12.2M |
|
2519
iQIYI
IQ
$1.31B
| $9.08M | ﹤0.01% |
1,139,205
-56,494
| -5% | -$586K |
|
|
FSP
2520
Franklin Street Properties
FSP
$46.3M
| $9.08M | ﹤0.01% |
1,956,990
-84,513
| -4% | -$412K |
|
2521
PetMed Express
PETS
$43M
| $9.08M | ﹤0.01% |
337,815
-6,760
| -2% | -$195K |
|
2522
Amerant Bancorp
AMTB
$1.15B
| $9.05M | ﹤0.01% |
365,713
+1,732
| +0.5% | +$40.9K |
|
2523
Groupon
GRPN
$901M
| $9.04M | ﹤0.01% |
396,161
+2,036
| +0.5% | +$60.2K |
|
2524
Angi Inc
ANGI
$176M
| $9.03M | ﹤0.01% |
73,167
-2,147
| -3% | -$247K |
|
2525
BioXcel Therapeutics
BTAI
$34.9M
| $9.02M | ﹤0.01% |
18,565
+1,264
| +7% | +$556K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.